Wegovy, Ozempic, Mounjaro, and Zepbound (as well as compound options such as Semaglutide and Tirzepatide) are some of the GLP-1s that Miami Primary prescribes, and they are easy to use
While they may offer benefits, they come with more significant considerations: Source quality matters: Not all compounding pharmacies follow strict standards No established protocols: Dosing varies widely Limited human safety data: Most research is preclinical Potential for side effects: Including injection site reactions, immune responses, and unknown long-term effects Regulatory status: Most are not FDA-approved for any medical indication Safety Considerations and Final Thoughts Peptides are an exciting area of research, and we are optimistic about their potential role in plastic surgery recovery
Common Questions Should I stop tirzepatide if I notice hair loss
Why it's GLP-1 friendly: One of the best protein-to-calorie ratios on my entire site
Escitalopram carries a known dose-dependent risk of prolonging the QT interval, which can predispose individuals to arrhythmias